Susquehanna Fundamental Investments, LLC Ac Immune Sa Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $59,320 - $89,969	-24,717 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $6,300 - $9,288	-1,800 Reduced 6.79%	24,717 $99,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $149,290 - $233,672	-30,909 Reduced 53.82%	26,517 $131,000
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $196,019 - $263,677	31,616 Added 122.5%	57,426 $385,000
Q2 2021 Aug 11, 2021	SELL	$6.04 - $8.37 $168,987 - $234,175	-27,978 Reduced 52.02%	25,810 $205,000
Q1 2021 May 17, 2021	SELL	$5.32 - $8.96 $100,016 - $168,448	-18,800 Reduced 25.9%	53,788 $409,000
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $85,868 - $107,191	19,210 Added 35.99%	72,588 $375,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $255,146 - $483,604	53,378 New	53,378 $260,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.